OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
The bio/pharma industry adjusts processes to meet demand for therapies.
): Outsourcing method development offers multiple benefits to companies.
July 19, 2021
Manufacturers seek more sustainable options for temperature-controlled packaging.
July 15, 2021
CDMO Idifarma has launched a new service aimed at delivering an accelerated pathway for complex drugs.
July 12, 2021
Purisys is now certified for ISO 17025 for testing and calibration laboratories and ISO 17034 for reference material producers
July 08, 2021
LGM Pharma will offer contract analytical testing and stability services to pharmaceutical developers and manufacturers.
July 02, 2021
CMOs and CDMOs adjust business processes as demand for COVID-19 treatments and non-pandemic related therapies puts pressure on the bio/pharma industry.
July 01, 2021
The extended manufacturing agreement between Pinteon and Lonza enables future clinical production of PNT001, a novel Tau antibody therapeutic that targets Alzheimer's disease and traumatic brain injury.
Selexis and KBI Biopharma will use integrated services to advance Immatics’ TCR bispecifics drug development program to the IND stage.
WuXi STA’s Delaware campus will contain clinical and commercial manufacturing capabilities for small molecules and novel molecular modalities.
Developing bioassay methods requires a new approach for cell and gene therapy drug development.
June 30, 2021
CDMO Yposkesi will increase its current gene therapy vector capacity through French government’s “Plan de Relance” scheme.